In a 26-week , randomised controlled trial ( ELEGANT ) , conducted in the outpatient departments of one academic and one large non-academic teaching hospital in the Netherlands , adult patients with type 2 diabetes with 4 % weight gain during short-term ( 16 months ) insulin therapy received either open-label addition of liraglutide 1.8 mg/day ( n = 26 ) or continued standard therapy ( n = 24 ) .